Target intelligence / Profile preview

Golgi SNAP receptor complex member 2 (GOSR2)

Target
GOSR2
Molecular classification
Qb-SNARE protein, Trafficking membrane protein, Soluble NSF attachment protein receptor (SNARE) family, Vesicular trafficking protein
01

Overview

Golgi SNAP receptor complex member 2 (GOSR2) is a trafficking membrane protein that serves as a Qb-SNARE, facilitating the transport of proteins from the endoplasmic reticulum (ER) and ER-Golgi intermediate compartment (ERGIC) to the medial and trans-Golgi network[3][4][5]. It is an integral part of the SNARE complex, interacting with other SNAREs—such as syntaxin-5, Bet1, and Sec22b—to mediate vesicle docking and fusion events that are essential for intracellular protein trafficking[5]. Mutations in the GOSR2 gene disrupt these trafficking processes and cause a spectrum of neurologic diseases, most notably North Sea progressive myoclonus epilepsy (NS-PME) and congenital muscular dystrophy, typically resulting in epilepsy, myoclonus, muscle weakness, and motor development delays, but generally with preserved cognition[1][2][5]. There are three main transcript variants of GOSR2, and disease mutations tend to affect highly conserved sites within its SNARE motif critical for complex formation and function[2][5][3]. No direct interacting drugs or established biomarker or screening paradigms are reported for GOSR2 as of current knowledge.

Other names
GS27Bos127 kDa Golgi SNARE proteinMembrinEPM6MYOS
02

Biological functions

Protein transport between medial- and trans-Golgi compartmentsVesicle-mediated intracellular trafficking (ER to Golgi, ER-Golgi intermediate compartment to Golgi)Assembly of SNARE complexes for membrane fusion
03

Disease associations

Neurodegenerative disease (progressive myoclonus epilepsy, North Sea PME)Congenital muscular dystrophyMotor disorders (ataxia, motor delay, hypotonia)
04

Safety considerations

Pathogenic variants cause progressive neurologic disorders with severe motor dysfunctionSome phenotypes include epilepsy, muscle weakness, and cognitive preservation

Beyond the preview

Go deeper on Golgi SNAP receptor complex member 2 (GOSR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golgi SNAP receptor complex member 2 (GOSR2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call